(2020) Cerium oxide nanoparticles: A promising tool for the treatment of fibrosarcoma in-vivo. Mater Sci Eng C Mater Biol Appl. p. 110533. ISSN 1873-0191 (Electronic) 0928-4931 (Linking)
Full text not available from this repository.
Abstract
In this study, we used cerium oxide nanoparticles and evaluated their anti-cancer effects in a mouse model of fibrosarcoma. For evaluation of anti-cancer effects of nanoceria, tumor volume measurement, TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) assay, quantitative real-time PCR (qPCR) for Bax and Bcl2 genes, a panel of liver and kidney function tests and hematoxylin-eosin staining were done. Nanoceria dominantly accumulated in the tumor and it could significantly decrease tumor growth and volume in tumor-bearing mice that received nanoceria for four weeks. Cerium oxide nanoparticle showed potential anti-cancer properties against fibrosarcoma.
| Item Type: | Article |
|---|---|
| Keywords: | Bax Bcl2 Cerium oxide nanoparticles Fibrosarcoma TUNEL of interest. |
| Subjects: | QZ Pathology > QZ 200-380 Neoplasms WE Musculoskeletal System > WE 200-259 Bones |
| Divisions: | Cardiovascular Research Institute > Isfahan Cardiovascular Research Center |
| Page Range: | p. 110533 |
| Journal or Publication Title: | Mater Sci Eng C Mater Biol Appl |
| Journal Index: | Pubmed, ISI |
| Volume: | 109 |
| Identification Number: | https://doi.org/10.1016/j.msec.2019.110533 |
| ISSN: | 1873-0191 (Electronic) 0928-4931 (Linking) |
| Depositing User: | Zahra Otroj |
| URI: | http://eprints.mui.ac.ir/id/eprint/11726 |
Actions (login required)
 |
View Item |